Understanding the effects of opioid exposure during pregnancy on child development
HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium
This study is looking at how using opioids during pregnancy might impact the health and development of babies, by following both babies who were exposed to opioids before birth and those who weren't, to see how they grow and develop over the first two years of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project ID | NIH-11001637 on NIH RePORTER |
What this research studies
This research investigates how maternal opioid use during pregnancy affects the health and development of children. It involves a longitudinal study that follows infants exposed to opioids in utero and compares their outcomes to those of unexposed infants. The study aims to assess brain structure, connectivity, and various medical and behavioral outcomes over the first two years of life. Additionally, it explores how factors like the home environment and maternal mental health influence these developmental trajectories.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants who were exposed to opioids in utero and their families.
Not a fit: Patients who were not exposed to opioids during pregnancy are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and interventions for children affected by prenatal opioid exposure.
How similar studies have performed: Previous research has shown promising results in understanding the impacts of prenatal substance exposure, making this study a continuation of important work in this area.
Where this research is happening
Research Triangle Park, United States
- Research Triangle Institute — Research Triangle Park, United States (Active)
Researchers
- Principal investigator: Bann, Carla M — Research Triangle Institute
- Study coordinator: Bann, Carla M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.